Safety of lixisenatide versus sulfonylurea added to basal insulin treatment in people with type 2 diabetes mellitus who elect to fast during Ramadan (LixiRam): An international, randomized, open-label trial
2019 ◽
Vol 150
◽
pp. 331-341
◽
Keyword(s):
2017 ◽
Vol 43
(2)
◽
pp. 110-124
◽
Keyword(s):
2010 ◽
Vol 32
(5)
◽
pp. 896-908
◽
2004 ◽
Vol 26
(6)
◽
pp. 889-901
◽
Keyword(s):
2020 ◽
Vol 163
◽
pp. 108148
Keyword(s):
2015 ◽
Vol 69
(11)
◽
pp. 1281-1288
◽
Keyword(s):
Keyword(s):